decitabine
mgi pharma,novo nordisk,supergen
['leukemia', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'leusm', 'decitabine', 'mds', 'novo ']
#ash22 #leusm efficace: ph3 randomized 10day decitabine vs intensive chemo (7+3) as bridge to allohct in age 60+ aml, multiconsortium study, efficacy presented at #eha22, now presenting hrqol assessment. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)